Literature DB >> 22308318

Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Keiko Takahashi1, Raymond L Mernaugh, David B Friedman, Rebecca Weller, Nobuo Tsuboi, Hironobu Yamashita, Vito Quaranta, Takamune Takahashi.   

Abstract

CD148 is a receptor-type protein tyrosine phosphatase that is expressed in several cell types, including vascular endothelial cells and duct epithelial cells. Growing evidence demonstrates a prominent role for CD148 in negative regulation of growth factor signals, suppressing cell proliferation and transformation. However, its extracellular ligand(s) remain unknown. To identify the ligand(s) of CD148, we introduced HA-tagged CD148 into cultured endothelial cells and then isolated its interacting extracellular protein(s) by biotin surface labeling and subsequent affinity purifications. The binding proteins were identified by mass spectrometry. Here we report that soluble thrombospondin-1 (TSP1) binds to the extracellular part of CD148 with high affinity and specificity, and its binding increases CD148 catalytic activity, leading to dephosphorylation of the substrate proteins. Consistent with these findings, introduction of CD148 conferred TSP1-mediated inhibition of cell growth to cells which lack CD148 and TSP1 inhibition of growth. Further, we demonstrate that TSP1-mediated inhibition of endothelial cell growth is antagonized by soluble CD148 ectodomain as well as by CD148 gene silencing. These findings provide evidence that CD148 functions as a receptor for TSP1 and mediates its inhibition of cell growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22308318      PMCID: PMC3277540          DOI: 10.1073/pnas.1106171109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1.

Authors:  M Kovalenko; K Denner; J Sandström; C Persson; S Gross; E Jandt; R Vilella; F Böhmer; A Ostman
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

2.  Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.

Authors:  Helena L Palka; Morag Park; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

3.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; S E Crawford; M Febbraio; R L Silverstein; N Bouck
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

4.  Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation.

Authors:  Z Li; L He; K Wilson; D Roberts
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

5.  Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium.

Authors:  D M Knowles; B Tolidjian; C Marboe; V D'Agati; M Grimes; L Chess
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

6.  Protein tyrosine phosphatase CD148-mediated inhibition of T-cell receptor signal transduction is associated with reduced LAT and phospholipase Cgamma1 phosphorylation.

Authors:  J E Baker; R Majeti; S G Tangye; A Weiss
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

7.  A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development.

Authors:  Takamune Takahashi; Keiko Takahashi; Patricia L St John; Paul A Fleming; Takuya Tomemori; Toshio Watanabe; Dale R Abrahamson; Christopher J Drake; Takuji Shirasawa; Thomas O Daniel
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

8.  An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.

Authors:  Rodolfo Iuliano; Francesco Trapasso; Ilaria Le Pera; Filippo Schepis; Irene Samà; Alessandra Clodomiro; Kristoffel R Dumon; Massimo Santoro; Lorenzo Chiariotti; Giuseppe Viglietto; Alfredo Fusco
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

9.  Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

Authors:  Claudia A L Ruivenkamp; Tom van Wezel; Carlo Zanon; Alphons P M Stassen; Cestmir Vlcek; Tamás Csikós; Anita M Klous; Nikos Tripodis; Anastassis Perrakis; Lucie Boerrigter; Peter C Groot; Jan Lindeman; Wolter J Mooi; Gerrit A Meijjer; Gert Scholten; Hans Dauwerse; Vaclav Paces; Nico van Zandwijk; Gert Jan B van Ommen; Peter Demant
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

10.  Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.

Authors:  Maria Grazia Lampugnani; Adriana Zanetti; Monica Corada; Takamune Takahashi; Giovanna Balconi; Ferruccio Breviario; Fabrizio Orsenigo; Anna Cattelino; Rolf Kemler; Thomas O Daniel; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

View more
  25 in total

1.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

Review 2.  Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  Int J Biochem Cell Biol       Date:  2016-05-06       Impact factor: 5.085

3.  Differential intolerance to loss of function and missense mutations in genes that encode human matricellular proteins.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  J Cell Commun Signal       Date:  2021-01-07       Impact factor: 5.782

4.  The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition.

Authors:  Masatoshi Yamamoto; Shizue Ohsawa; Kei Kunimasa; Tatsushi Igaki
Journal:  Nature       Date:  2017-01-16       Impact factor: 49.962

5.  Csk/CD148 and platelet SFK activation: a balancing act!

Authors:  Jieqing Zhu
Journal:  Blood       Date:  2018-03-08       Impact factor: 22.113

Review 6.  Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.

Authors:  Lutz Tautz; Yotis A Senis; Cécile Oury; Souad Rahmouni
Journal:  Bioorg Med Chem       Date:  2015-04-04       Impact factor: 3.641

7.  The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases.

Authors:  Tamiko R Katsumoto; Makoto Kudo; Chun Chen; Aparna Sundaram; Elliott C Callahan; Jing W Zhu; Joseph Lin; Connor E Rosen; Boryana N Manz; Jae W Lee; Michael A Matthay; Xiaozhu Huang; Dean Sheppard; Arthur Weiss
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

8.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

9.  Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells.

Authors:  Katarzyna M Skrzypczynska; Jing W Zhu; Arthur Weiss
Journal:  Immunity       Date:  2016-11-23       Impact factor: 31.745

Review 10.  Functions of Thrombospondin-1 in the Tumor Microenvironment.

Authors:  Sukhbir Kaur; Steven M Bronson; Dipasmita Pal-Nath; Thomas W Miller; David R Soto-Pantoja; David D Roberts
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.